Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer

Details for Australian Patent Application No. 2012202262 (hide)

Owner Agensys, Inc.

Inventors Raitano, Arthur B.; Jakobovits, Aya; Faris, Mary; Ge, Wangmao

Agent FB Rice

Pub. Number AU-A-2012202262

Parent 2008207531

Filing date 18 April 2012

Wipo publication date 10 May 2012

International Classifications

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

3 May 2012 Complete Application Filed

10 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202262

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202263-Multi-layer projection displays

2012202261-Test data supply chain manager for an integrated testing platform